Possible Strategies for the Treatment of Myasthenia Gravis and Other Autoimmune Diseases^a

This publication has 12 references indexed in Scilit:

• Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
  Proceedings of the National Academy of Sciences, 1985
• T cell tolerance studied at the level of antigenic determinants. I. Latent reactivity to lysozyme peptides that lack suppressogenic epitopes can be revealed in lysozyme-tolerant mice.
  The Journal of Experimental Medicine, 1985
• ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY
  The Lancet, 1983
• Functional clonal deletion of cytotoxic T-lymphocyte precursors in chimeric thymus produced in vitro from embryonic Anlagen.
  Proceedings of the National Academy of Sciences, 1983
• Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin.
  The Journal of Experimental Medicine, 1983
• Cellular Mechanisms of Immunologic Tolerance
  Annual Review of Immunology, 1983
• Clonal anergy: the universally anergic B lymphocyte.
  Proceedings of the National Academy of Sciences, 1982
• Functional clonal deletion in immunological tolerance to major histocompatibility complex antigens.
  Proceedings of the National Academy of Sciences, 1981
• Clonal anergy: Persistence in tolerant mice of antigen-binding B lymphocytes incapable of responding to antigen or mitogen
  Proceedings of the National Academy of Sciences, 1980
• EFFECTOR CELL BLOCKADE
  The Journal of Experimental Medicine, 1974